134 related articles for article (PubMed ID: 38193576)
1. Gene correction and overexpression of TNNI3 improve impaired relaxation in engineered heart tissue model of pediatric restrictive cardiomyopathy.
Hasegawa M; Miki K; Kawamura T; Takei Sasozaki I; Higashiyama Y; Tsuchida M; Kashino K; Taira M; Ito E; Takeda M; Ishida H; Higo S; Sakata Y; Miyagawa S
Dev Growth Differ; 2024 Feb; 66(2):119-132. PubMed ID: 38193576
[TBL] [Abstract][Full Text] [Related]
2. Impaired Relaxation in Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Pathogenic
Wang R; Hasegawa M; Suginobe H; Yoshihara C; Ishii Y; Ueyama A; Ueda K; Hashimoto K; Hirose M; Ishii R; Narita J; Watanabe T; Kawamura T; Taira M; Ueno T; Miyagawa S; Ishida H
J Am Heart Assoc; 2024 Mar; 13(6):e032375. PubMed ID: 38497452
[TBL] [Abstract][Full Text] [Related]
3. Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery.
Wang BZ; Nash TR; Zhang X; Rao J; Abriola L; Kim Y; Zakharov S; Kim M; Luo LJ; Morsink M; Liu B; Lock RI; Fleischer S; Tamargo MA; Bohnen M; Welch CL; Chung WK; Marx SO; Surovtseva YV; Vunjak-Novakovic G; Fine BM
Cell Rep Med; 2023 Mar; 4(3):100976. PubMed ID: 36921598
[TBL] [Abstract][Full Text] [Related]
4. Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for
Kondo T; Higo S; Shiba M; Kohama Y; Kameda S; Tabata T; Inoue H; Okuno S; Ogawa S; Nakamura S; Takeda M; Ito E; Li J; Liu L; Kuramoto Y; Lee JK; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Circ Genom Precis Med; 2022 Oct; 15(5):e003522. PubMed ID: 35861968
[TBL] [Abstract][Full Text] [Related]
5. [Genetic analysis of a child with restricted cardiomyopathy and phenylketonuria and a literature review].
Wang F; Xiao M; Sun Q; Jia L; Lyu A; Yao X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):990-997. PubMed ID: 37532500
[TBL] [Abstract][Full Text] [Related]
6. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.
Wu H; Yang H; Rhee JW; Zhang JZ; Lam CK; Sallam K; Chang ACY; Ma N; Lee J; Zhang H; Blau HM; Bers DM; Wu JC
Eur Heart J; 2019 Dec; 40(45):3685-3695. PubMed ID: 31219556
[TBL] [Abstract][Full Text] [Related]
7. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.
Shiba M; Higo S; Kondo T; Li J; Liu L; Ikeda Y; Kohama Y; Kameda S; Tabata T; Inoue H; Nakamura S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Hum Mol Genet; 2021 Jul; 30(15):1384-1397. PubMed ID: 33949662
[TBL] [Abstract][Full Text] [Related]
9. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
[TBL] [Abstract][Full Text] [Related]
10. Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy.
Li Y; Charles PY; Nan C; Pinto JR; Wang Y; Liang J; Wu G; Tian J; Feng HZ; Potter JD; Jin JP; Huang X
J Mol Cell Cardiol; 2010 Sep; 49(3):402-11. PubMed ID: 20580639
[TBL] [Abstract][Full Text] [Related]
11. Role of Whole-exome Sequencing in Phenotype Classification and Clinical Treatment of Pediatric Restrictive Cardiomyopathy.
Ding WH; Han L; Xiao YY; Mo Y; Yang J; Wang XF; Jin M
Chin Med J (Engl); 2017 Dec; 130(23):2823-2828. PubMed ID: 29176140
[TBL] [Abstract][Full Text] [Related]
12. Generation of human induced pluripotent stem cell line from a patient with restrictive cardiomyopathy.
Li J; Jiang J; Ye L; Lian Z; Gong H; Lei W; Dai Y; Hu S
Stem Cell Res; 2024 Apr; 76():103370. PubMed ID: 38428347
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.
Mouton JM; Pellizzon AS; Goosen A; Kinnear CJ; Herbst PG; Brink PA; Moolman-Smook JC
Cardiovasc J Afr; 2015; 26(2):63-9. PubMed ID: 25940119
[TBL] [Abstract][Full Text] [Related]
14. Restrictive cardiomyopathy: from genetics and clinical overview to animal modeling.
Chintanaphol M; Orgil BO; Alberson NR; Towbin JA; Purevjav E
Rev Cardiovasc Med; 2022 Mar; 23(3):108. PubMed ID: 35345275
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent diastolic dysfunction and early death in a mouse model with cardiac troponin mutations.
Li Y; Zhang L; Jean-Charles PY; Nan C; Chen G; Tian J; Jin JP; Gelb IJ; Huang X
J Mol Cell Cardiol; 2013 Sep; 62():227-36. PubMed ID: 23810866
[TBL] [Abstract][Full Text] [Related]
16. Development of a 3-Dimensional Model to Study Right Heart Dysfunction in Pulmonary Arterial Hypertension: First Observations.
Llucià-Valldeperas A; Smal R; Bekedam FT; Cé M; Pan X; Manz XD; Wijnker PJM; Vonk-Noordegraaf A; Bogaard HJ; Goumans MJ; Man FS
Cells; 2021 Dec; 10(12):. PubMed ID: 34944102
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cell derived cardiac models: effects of Thymosin β4.
Ziegler T; Hinkel R; Kupatt C
Expert Opin Biol Ther; 2018 Jul; 18(sup1):111-120. PubMed ID: 30063852
[TBL] [Abstract][Full Text] [Related]
18. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
[TBL] [Abstract][Full Text] [Related]
19. Challenging of ECMO application in pediatric restrictive cardiomyopathy: case report of a novel
Jin Y; Xu J; Hua Y; Zhang H; Li Y
Front Cardiovasc Med; 2024; 11():1365209. PubMed ID: 38854656
[TBL] [Abstract][Full Text] [Related]
20. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
